Vaccination against feline leukaemia virus
Jarrett, O.
Veterinary Record 134(8): 198
1994
ISSN/ISBN: 0042-4900 PMID: 8080515 Document Number: 435621
The prevalence of feline leukaemia virus (FeLV) infection found in surveys of healthy cats in the UK was low (1.4-6%). The need for prevaccination testing is discussed and the possibility is raised that vaccination may be unnecessary since the risk of a healthy cat in the general population becoming persistently infected is very low. However, when individual cats are considered, vaccination will still reduce the risk of infection and testing may be dispensed with if cost is a major consideration. A disclaimer of responsibility for the future FeLV status of the cat may be needed if pre-vaccination testing is refused.
Document emailed within 1 workday
Related Documents
1991: Panel report on the colloquium on feline leukemia virus/feline immunodeficiency virus: tests and vaccination Journal of the American Veterinary Medical Association 199(10): 1273-1277Testa, N.G.; Orions, D.E.; Lord, B.I. 1988: A feline model for the myelodysplastic syndrome: pre-leukaemic abnormalities caused in cats by infection with a new isolate of feline leukaemia virus (FeLV), AB/GM1 Haematologica 73(4): 317-320
Jirjis, F.F.; Davis, T.; Lane, J.; Carritt, K.; Sweeney, D.; Williams, J.; Wasmoen, T. 2010: Protection against feline leukemia virus challenge for at least 2 years after vaccination with an inactivated feline leukemia virus vaccine Veterinary Therapeutics: Research in Applied Veterinary Medicine 11(2): E1-E6
Briggs, M.B.; Ott, R.L. 1986: Feline leukemia virus infection in a captive cheetah and the clinical and antibody response of six captive cheetahs to vaccination with a subunit feline leukemia virus vaccine Journal of the American Veterinary Medical Association 189(9): 1197-1199
Lutz, H.; Lehmann, R.; Winkler, G.; Kottwitz, B.; Dittmer, A.; Wolfensberger, C.; Arnold, P. 1990: Feline immunodeficiency virus in Switzerland: clinical aspects and epidemiology in comparison with feline leukemia virus and coronaviruses Schweizer Archiv für Tierheilkunde 132(5): 217-225
Hawks, D.M.; Legendre, A.M.; Rohrbach, B.W.; Sebring, R.; Chavez, L.; Chu, H.J.; Acree, W.M. 1991: Antibody response of kittens after vaccination followed by exposure to feline leukemia virus-infected cats Journal of the American Veterinary Medical Association 199(10): 1463-1469
Azocar, J.; Essex, M. 1979: Susceptibility of human cell lines to feline leukemia virus and feline sarcoma virus Journal of the National Cancer Institute 63(5): 1179-1184
Jarrett, O.; Pacitti, A.M.; Hosie, M.J.; Reid, G. 1991: Comparison of diagnostic methods for feline leukemia virus and feline immunodeficiency virus Journal of the American Veterinary Medical Association 199(10): 1362-1364
Grant, C.K.; Essex, M.; Pedersen, N.C.; Hardy, W.D.; Stephenson, J.R.; Cotter, S.M.; Theilen, G.H. 1978: Lysis of feline lymphoma cells by complement-dependent antibodies in feline leukemia virus contact cats. Correlation of lysis and antibodies to feline oncornavirus-associated cell membrane antigen Journal of the National Cancer Institute 60(1): 161-166
Camero, M.; Cavalli, A.; Bozzo, G.; Decaro, N.; Aliberti, A.; Martella, V.; Pratelli, A.; Buonavoglia, C. 2004: A severe dual infection by feline panleukopenia virus and feline calicivirus in an adult cat New Microbiologica 27(1): 79-82
Rojko, J.L.; Fulton, R.M.; Rezanka, L.J.; Williams, L.L.; Copelan, E.; Cheney, C.M.; Reichel, G.S.; Neil, J.C.; Mathes, L.E.; Fisher, T.G. 1992: Lymphocytotoxic strains of feline leukemia virus induce apoptosis in feline T4-thymic lymphoma cells Laboratory Investigation; a Journal of Technical Methods and Pathology 66(4): 418-426
Olsen, R.G.; Lafrado, L.J.; Lewis, M.G.; Mathes, L.E.; Haffer, K.; Sharpee, R. 1987: Feline leukemia virus current status of the feline acquired immune deficiency syndrome and immunoprevention Wormser, G P (Ed ) Aids, Acquired Immune Deficiency Syndrome, And Other Manifestations Of Hiv Infection: Epidemiology, Etiology, Immunology, Clinical Manifestations, Pathology, Control, Treatment And Prevention Xliii+1103p Noyes Publications: Park Ridge, New Jersey, Usa Illus 160-185
Siebelink, C.H.; Windrich, R.W.; Chu, I.; Groen, J.; Weijer, K.; UytdeHaag, F.G.; Osterhaus, A.D. 1990: An enzyme linked immunosorbent assay (ELISA) for the detection of feline immunodeficiency virus (FIV) antigen in cell culture and FIV specific antibodies in feline serum Developments in Biological Standardization 72: 189-196
Neil, J.C.; Onions, D.E. 1985: Feline leukaemia viruses: molecular biology and pathogenesis Anticancer Research 5(1): 49-63
Rice, J.B.; Olsen, R.G. 1981: Feline oncovirus-associated cell membrane antigen and feline leukemia virus group-specific antigen expression in bone marrow and serum Journal of the National Cancer Institute 66(4): 737-743
Starkebaum, G.; Loughran, T.P.; Kalyanaraman, V.S.; Kadin, M.E.; Kidd, P.G.; Singer, J.W.; Ruscetti, F.W. 1987: Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia Lancet 1(8533): 596-599
Zuffa, T. 1987: The growth of attenuated strains of canine parvovirus, mink enteritis virus, feline panleukopenia virus, and rabies virus on various types of cell cultures Veterinarni Medicina 32(10): 633-640
Jarrett, O. 1990: Vaccination against feline retroviruses Developments in Biological Standardization 72: 185-188
Ellis, J.A. 1999: Feline vaccination protocol needs further scrutiny Journal of the American Veterinary Medical Association 215(5): 620
Uno, H.; Kawano, K.; Matsuoka, H.; Tsuda, K. 1988: HLA and adult T cell leukaemia: HLA-linked genes controlling susceptibility to human T cell leukaemia virus type i Clinical and Experimental Immunology 71(2): 211-216